Constantine Davides
Stock Analyst at Citizens
(1.06)
# 3,866
Out of 5,090 analysts
115
Total ratings
31.43%
Success rate
-19.99%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $95.43 | +27.84% | 6 | Dec 4, 2025 | |
| EVH Evolent Health | Maintains: Market Outperform | $13 → $11 | $4.01 | +174.31% | 11 | Nov 10, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $23.92 | +29.60% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $14.70 | +63.27% | 11 | Nov 7, 2025 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $16.57 | +44.84% | 12 | Nov 7, 2025 | |
| OPCH Option Care Health | Maintains: Market Outperform | $38 → $36 | $29.73 | +21.09% | 7 | Oct 31, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $35.25 | +36.17% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $114.51 | +30.99% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $20.46 | - | 2 | Jun 18, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $9.57 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.73 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $76.30 | +48.10% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $32.82 | -20.78% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $178.83 | +38.68% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $24.63 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $7.56 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.01 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.22 | +330.33% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.64 | +19,517.07% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $27.80 | -46.04% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $20.76 | +8.38% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.15 | +169.84% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.18 | +1,083.33% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $2.03 | +17,633.99% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.76 | +184,001.37% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $1.17 | +3,318.80% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.31 | +1,826.78% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.61 | +49,589.44% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $2.30 | +216,421.74% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.48 | +17,582.55% | 2 | Sep 23, 2022 |
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $95.43
Upside: +27.84%
Evolent Health
Nov 10, 2025
Maintains: Market Outperform
Price Target: $13 → $11
Current: $4.01
Upside: +174.31%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $23.92
Upside: +29.60%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $14.70
Upside: +63.27%
AMN Healthcare Services
Nov 7, 2025
Maintains: Market Outperform
Price Target: $22 → $24
Current: $16.57
Upside: +44.84%
Option Care Health
Oct 31, 2025
Maintains: Market Outperform
Price Target: $38 → $36
Current: $29.73
Upside: +21.09%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $35.25
Upside: +36.17%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $114.51
Upside: +30.99%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $20.46
Upside: -
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.57
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.73
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $76.30
Upside: +48.10%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $32.82
Upside: -20.78%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $178.83
Upside: +38.68%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $24.63
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $7.56
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $24.01
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.22
Upside: +330.33%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.64
Upside: +19,517.07%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $27.80
Upside: -46.04%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $20.76
Upside: +8.38%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.15
Upside: +169.84%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.18
Upside: +1,083.33%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $2.03
Upside: +17,633.99%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.76
Upside: +184,001.37%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $1.17
Upside: +3,318.80%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.31
Upside: +1,826.78%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.61
Upside: +49,589.44%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $2.30
Upside: +216,421.74%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.48
Upside: +17,582.55%